Equities researchers at Needham & Company LLC initiated coverage on shares of Express Scripts Holding Company (NASDAQ:ESRX) in a research note issued on Friday, Marketbeat.com reports. The firm set a “hold” rating on the stock.

A number of other equities research analysts have also recently weighed in on the company. BidaskClub cut Express Scripts Holding from a “hold” rating to a “sell” rating in a research note on Wednesday, July 12th. Cowen and Company reissued an “outperform” rating and set a $83.00 target price on shares of Express Scripts Holding in a research note on Friday, June 9th. ValuEngine cut Express Scripts Holding from a “buy” rating to a “hold” rating in a research note on Friday, June 2nd. Evercore ISI lowered their target price on Express Scripts Holding from $68.50 to $59.00 and set an “in-line” rating for the company in a research note on Wednesday, April 26th. Finally, Morgan Stanley lowered their target price on Express Scripts Holding from $71.00 to $52.00 and set an “underweight” rating for the company in a research note on Wednesday, April 26th. Four equities research analysts have rated the stock with a sell rating, thirteen have assigned a hold rating, five have issued a buy rating and one has issued a strong buy rating to the company’s stock. Express Scripts Holding presently has an average rating of “Hold” and an average price target of $71.89.

Express Scripts Holding (NASDAQ ESRX) traded down 0.22% during trading on Friday, hitting $62.50. The stock had a trading volume of 2,098,090 shares. The firm has a 50 day moving average of $62.74 and a 200-day moving average of $65.47. The company has a market cap of $37.10 billion, a P/E ratio of 11.33 and a beta of 0.90. Express Scripts Holding has a one year low of $57.80 and a one year high of $79.24.

Express Scripts Holding (NASDAQ:ESRX) last issued its quarterly earnings data on Monday, April 24th. The company reported $1.33 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.32 by $0.01. Express Scripts Holding had a return on equity of 25.64% and a net margin of 3.42%. The business had revenue of $24.65 billion during the quarter, compared to analysts’ expectations of $24.95 billion. During the same period in the previous year, the firm posted $1.22 earnings per share. The company’s revenue was down .6% on a year-over-year basis. Equities analysts anticipate that Express Scripts Holding will post $6.97 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: This report was originally posted by American Banking News and is owned by of American Banking News. If you are viewing this report on another publication, it was illegally copied and republished in violation of U.S. and international trademark and copyright laws. The original version of this report can be accessed at https://www.americanbankingnews.com/2017/07/22/express-scripts-holding-company-esrx-earns-hold-rating-from-analysts-at-needham-company-llc.html.

In other news, VP Phyllis S. Anderson sold 1,100 shares of the business’s stock in a transaction dated Friday, May 19th. The stock was sold at an average price of $60.08, for a total value of $66,088.00. Following the completion of the sale, the vice president now directly owns 11,108 shares of the company’s stock, valued at approximately $667,368.64. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.68% of the stock is currently owned by insiders.

Several hedge funds have recently bought and sold shares of the stock. Vanguard Group Inc. increased its stake in Express Scripts Holding by 1.6% in the first quarter. Vanguard Group Inc. now owns 40,251,311 shares of the company’s stock valued at $2,652,964,000 after buying an additional 649,400 shares during the last quarter. State Street Corp increased its stake in Express Scripts Holding by 1.1% in the first quarter. State Street Corp now owns 27,060,709 shares of the company’s stock valued at $1,783,569,000 after buying an additional 298,341 shares during the last quarter. Dodge & Cox purchased a new stake in Express Scripts Holding during the fourth quarter valued at $1,456,850,000. Barrow Hanley Mewhinney & Strauss LLC increased its stake in Express Scripts Holding by 4.2% in the first quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 17,612,834 shares of the company’s stock valued at $1,160,862,000 after buying an additional 704,218 shares during the last quarter. Finally, Bank of New York Mellon Corp increased its stake in Express Scripts Holding by 0.3% in the first quarter. Bank of New York Mellon Corp now owns 10,960,709 shares of the company’s stock valued at $722,420,000 after buying an additional 32,854 shares during the last quarter. 88.47% of the stock is owned by institutional investors and hedge funds.

About Express Scripts Holding

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Analyst Recommendations for Express Scripts Holding (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related companies with MarketBeat.com's FREE daily email newsletter.